Terasaki W L, Brooker G
J Biol Chem. 1977 Feb 10;252(3):1041-50.
Adenosine 3':5'-monophosphate (cyclic AMP), a mediator of hormone action in a variety of tissues, has been measured in its free and bound forms in intact cardiac tissue. We have used a rapid high dilution technique which involves tissue homogenization, subcellular fractionation, and separation of bound from free cyclic AMP by Millopore filtration. The precision of this method is dependent upon minimization of binding and dissociation of cyclic AMP that occur during the preparation and handling of tissue homogenates. In each experiment, a tracer of cyclic [3H]AMP prebound to isolated cardiac binding protein was freed of unbound cyclic [3H]AMP by Sephadex gel filtration and added to the tissue just prior to homogenization in cold EDTA buffer. This tracer was therefore treated identically to the sample through all subsequent dilution, fractionation, and filtration procedures, and provided an acurate internal monitor for total cyclic AMP dissociation during the course of the free-bound determination. Each tissue sample was then individually corrected for dissociation. Rapid dilution to produce a 1:1000 homogenate was found to lower endogenous cyclic AMP levels sufficiently to make binding (or rebinding) during the procedure negligible (less than 5%). Spontaneously beating rat right atria (controls) contained 5.96 +/- 0.28 pmol of cyclic AMP/mg of protein (n = 19) of which 41 and 14% were bound to soluble and particulate proteins, respectively. The remaining cyclic AMP was free. Pretreatment of the tissue with 1 muM isoproterenol (30 s at 30 degrees) increased both the bound and free forms of cyclic AMP (n = 8). While free cyclic AMP increased 420% with the catecholamine, the bound forms increased 240% (soluble) and 60% (particulate). Similar results were obtained when atria (n = 6) were treated with the phosphodiesterase inhibitor, methylisobutylxanthine (0.5 mM, 10 min at 30 degrees). When both agents were used together, cyclic AMP bound to soluble proteins was elevated 4-fold over control while free cyclic AMP increased 27-fold (n = 7), indicating saturation of the soluble sites. It could be calculated that less than one-third of these sites are occupied in the unstimulated cell. These sites may represent the R subunit of cyclic AMP-dependent protein kinase. The data suggest that half-maximal binding in vivo occurs at an intracellular free cyclic AMP concentration of about 1 muM.
3':5'-环磷酸腺苷(环磷腺苷)作为多种组织中激素作用的介质,已在完整心脏组织中对其游离形式和结合形式进行了测定。我们采用了一种快速高稀释技术,该技术包括组织匀浆、亚细胞分级分离以及通过微孔过滤将结合型环磷腺苷与游离型环磷腺苷分离。此方法的精度取决于在组织匀浆制备和处理过程中环磷腺苷结合和解离的最小化。在每个实验中,预先与分离的心脏结合蛋白结合的环[3H]腺苷酸示踪剂通过葡聚糖凝胶过滤去除未结合的环[3H]腺苷酸,并在冷EDTA缓冲液中匀浆前加入到组织中。因此,该示踪剂在所有后续的稀释、分级分离和过滤过程中与样品的处理方式相同,并为游离 - 结合型测定过程中环磷腺苷的总解离提供了准确的内部监测。然后对每个组织样品的解离进行单独校正。发现快速稀释至1:1000匀浆足以充分降低内源性环磷腺苷水平,使该过程中的结合(或再结合)可忽略不计(小于5%)。自发跳动的大鼠右心房(对照组)每毫克蛋白质含有5.96±0.28皮摩尔环磷腺苷(n = 19),其中41%和14%分别与可溶性蛋白和颗粒性蛋白结合。其余的环磷腺苷为游离形式。用1μM异丙肾上腺素(30℃,30秒)预处理组织可增加环磷腺苷的结合型和游离型(n = 8)。虽然游离环磷腺苷随着儿茶酚胺增加了420%,但结合型增加了240%(可溶性)和60%(颗粒性)。当心房(n = 6)用磷酸二酯酶抑制剂甲基异丁基黄嘌呤(0.5 mM,30℃,10分钟)处理时,得到了类似的结果。当两种药物一起使用时,与可溶性蛋白结合的环磷腺苷比对照升高了4倍,而游离环磷腺苷增加了27倍(n = 7),表明可溶性位点饱和。可以计算出在未受刺激的细胞中这些位点被占据的不到三分之一。这些位点可能代表环磷腺苷依赖性蛋白激酶的R亚基。数据表明,体内半数最大结合发生在细胞内游离环磷腺苷浓度约为1μM时。